Medivizor

Title of notification

Here comes the notification
X
 
icon
colorectal cancer | Research | 10 pages | source: British Journal of Surgery | Added Jul 08, 2019

Liver surgery is a safe treatment for patients with BRAF-positive colorectal cancer liver metastasis

This study investigated the outcomes of patients with BRAF-positive colorectal cancer liver-metastasis (CRLM; spread to the liver) undergoing surgery. Researchers suggested that surgery is associated with improved outcomes for these patients.

icon
colorectal cancer | Clinical Trial | Added Jul 05, 2019

Looking for patients with inoperable metastatic colorectal cancer to test a new immunotherapy

This phase 1/2 trial is examining the effectiveness of a new immunotherapy in the treatment of patients with advanced colorectal cancer (CRC). The main outcome to be measured will be tumor response to the treatment. This study is being conducted in Texas, USA.  

icon
colorectal cancer | Clinical Trial | Added Jul 01, 2019

Searching for patients with unresponsive cancer to test a new treatment

This phase 1/2 trial will investigate the safety of 9-ING-41, for treatment-resistant cancers.

The main outcome will be the number of treatment-related adverse events (TRAEs). This trial is recruiting in the United States.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Clinical Colorectal Cancer | Added Jun 30, 2019

Radiation therapy after surgery improves survival in patients with metastatic rectal cancer

This study investigated the survival outcomes in patients with rectal cancer after surgery with and without radiation therapy (RT). Researchers suggested that RT after surgery is associated with improved outcomes.

icon
colorectal cancer | Clinical Trial | Added Jun 28, 2019

Looking for patients with advanced colorectal cancer to test a new drug

This phase 1 study will investigate the dose range and effectiveness of an experimental drug, XmAb23104, in the treatment of advanced colorectal cancer and other solid tumors. 

The main outcome will be the safety and tolerability of XmAb23104. This trial is recruiting in Georgia, Texas, and Virginia, the United States.

icon
colorectal cancer | Clinical Trial | Added Jun 24, 2019

Searching for patients with colorectal cancer to test this new treatment combination

This phase 2 trial is examining the effectiveness and safety of navarixin (MK-7123) in combination with pembrolizumab (Keytruda) in patients with colorectal cancer (CRC). The main outcome to be measured will be the objective response rate (ORR; tumor shrinkage or disappearance). 

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Annals of Surgical Oncology | Added Jun 20, 2019

A comparison between local and radical surgery in early rectal cancer

This study investigated the effectiveness of local vs radical surgery in patients with rectal cancer. Researchers suggested that local surgery is associated with better outcomes in certain patients with early cancers.

icon
colorectal cancer | Research | 10 pages | source: Cancer Medicine | Added Jun 14, 2019

The risk of pelvic fracture in rectal cancer survivors who had radiotherapy

This study investigated the risk of pelvic fracture (PF) in patients with rectal cancer who received radiation therapy. Researchers suggested that there is an increased risk of PF in these patients.

icon
colorectal cancer | Clinical Trial | Added Jun 02, 2019

Looking for participants with advanced colorectal cancer to test a new targeted treatment with DS-8201a

This phase 2 trial is examining the effectiveness and safety of DS-8201a in the treatment of advanced HER2 positive colorectal cancer. The main outcome to be measured is the tumor response to the treatment and side effects. 

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: BMC cancer | Added May 30, 2019

Cetuximab improves the outcomes of previously untreated patients with metastatic colorectal cancer

This study investigated the effectiveness of first-line treatment with cetuximab (Erbitux) and bevacizumab (Avastin) in advanced colorectal cancer. Researchers suggested that cetuximab is associated with better outcomes when compared to bevacizumab.   

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?